Literature DB >> 29580854

Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-Jiao-Tai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis.

Wenbo Wang1, Linlin Zhao2, Zhenyu He3, Ning Wu4, Qiuxia Li5, Xinjian Qiu6, Lu Zhou7, Dongsheng Wang8.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Ge-Gen-Jiao-Tai-Wan (GGJTW) formula, derived from traditional Chinese herbal medicine, is composed of Pueraria montana var. lobata (Willd.) Sanjappa & Pradeep (Ge-Gen in Chinese), Coptis chinensis Franch (Huang-Lian), and Cinnamomum cassia (L.) J. Presl (Rou-Gui). GGJTW is used for treatment of diabetes in China, reflecting the potent hypoglycemic effect of its ingredients. However, little is known of the hypoglycemic effect of GGJTW and the underlying metabolic mechanism. AIM OF THE STUDY: This study aimed to investigate the hypoglycemic effect of GGJTW in type 2 diabetic rats and the metabolic mechanism of action.
MATERIALS AND METHODS: Ultra high-performance liquid chromatography coupled with quadrupole-time-of-flight tandem mass spectrometry (UHPLC-QTOF/MS)-based metabolomics approach was used for monitoring hyperglycaemia induced by high-sugar high-fat fodder and streptozotocin (STZ), and the protective effect of GGJTW. Dynamic fasting blood glucose (FBG) levels, body weight, and biochemical parameters, including lipid levels, hepatic-renal function, and hepatic histopathology were used to confirm the hyperglycaemic toxicity and attenuation effects. An orthogonal partial least squared-discriminant analysis (OPLS-DA) approach highlighted significant differences in the metabolome of the healthy control, diabetic, and drug-treated rats. The metabolomics pathway analysis (MetPA) and Kyoto encyclopedia of genes and genomes (KEGG) database were used to investigate the underlying metabolic pathways.
RESULTS: Metabolic profiling revealed 37 metabolites as the most potential biomarker metabolites distinguishing GGJTW-treated rats from model rats. Most of the metabolites were primarily associated with bile acid metabolism and lipid metabolism. The most critical pathway was primary bile acid biosynthesis pathway involving the up-regulation of the levels of cholic acid (CA), chenodeoxycholic acid (CDCA), taurocholic acid (TCA), glycocholic acid (GCA), taurochenodesoxycholic acid (TCDCA), and taurine.
CONCLUSIONS: The significantly-altered metabolite levels indicated the hypoglycemic effect of GGJTW on diabetic rats and the underlying metabolic mechanism. This study will be meaningful for the clinical application of GGJTW and valuable for further exploration of the mechanism.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chinese herbal medicine; Ge-Gen-Jiao-Tai-Wan; Metabolomics; Therapeutic effects; Type 2 diabetes; UHPLC-QTOF/MS

Mesh:

Substances:

Year:  2018        PMID: 29580854     DOI: 10.1016/j.jep.2018.03.026

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  19 in total

1.  UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.

Authors:  Yang Wang; Cong-Hui Wang; Yu-Fei Zhang; Liang Zhu; Hui-Min Lei; Ya-Bin Tang
Journal:  Metabolomics       Date:  2019-03-25       Impact factor: 4.290

2.  Gestational diabetes mellitus is associated with the neonatal gut microbiota and metabolome.

Authors:  Ting Chen; Yufeng Qin; Minjian Chen; Yuqing Zhang; Xu Wang; Tianyu Dong; Guanglin Chen; Xian Sun; Ting Lu; Richard Allen White; Peng Ye; Hein M Tun; Yankai Xia
Journal:  BMC Med       Date:  2021-05-27       Impact factor: 8.775

3.  Study on the dynamic changes and formation pathways of metabolites during the fermentation of black waxy rice wine.

Authors:  Li Jiang; Yingchun Mu; Su Wei; Yu Mu; Chi Zhao
Journal:  Food Sci Nutr       Date:  2020-03-27       Impact factor: 2.863

4.  Identification of Novel Biomarkers for Evaluating Disease Severity in House-Dust-Mite-Induced Allergic Rhinitis by Serum Metabolomics.

Authors:  Shaobing Xie; Hua Zhang; Zhihai Xie; Yongzhen Liu; Kelei Gao; Junyi Zhang; Shumin Xie; Fengjun Wang; Ruohao Fan; Weihong Jiang
Journal:  Dis Markers       Date:  2021-05-19       Impact factor: 3.434

5.  Microbiome and Metabolomics Reveal the Effects of Different Feeding Systems on the Growth and Ruminal Development of Yaks.

Authors:  Chun Huang; Fei Ge; Xixi Yao; Xian Guo; Pengjia Bao; Xiaoming Ma; Xiaoyun Wu; Min Chu; Ping Yan; Chunnian Liang
Journal:  Front Microbiol       Date:  2021-06-22       Impact factor: 5.640

6.  The Effect of Simvastatin on Gut Microbiota and Lipid Metabolism in Hyperlipidemic Rats Induced by a High-Fat Diet.

Authors:  Qing Zhang; Xiaoyun Fan; Rui Ye; Yuzhong Hu; Tingting Zheng; Rui Shi; Wenjian Cheng; Xucong Lv; Lijiao Chen; Peng Liang
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810

7.  UPLC-QTOF/MS-Based Lipidomic Profiling of Liver Qi-Stagnation and Spleen-Deficiency Syndrome in Patients with Hyperlipidemia.

Authors:  Piao Shenghua; Tan Shuyu; Li Kunping; Zhan Huixia; Xiao Xue; Guo Jiao
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-30       Impact factor: 2.629

8.  Rumen and plasma metabolomics profiling by UHPLC-QTOF/MS revealed metabolic alterations associated with a high-corn diet in beef steers.

Authors:  You Yang; Guozhong Dong; Zhi Wang; Jian Wang; Zhu Zhang; Junhui Liu
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

9.  Efficacy of Weikang Pian in Patients with Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Authors:  Lijing Yan; Lijin Yu; Linlin Zhao; Dongsheng Wang; Dilan Qin; Haiwei Fan; Ling Cheng; Musen Qiu; Xiao Chen; Lu Zhou; Juan Qiu; Jiamei Yao; Wenbo Wang; Xinjian Qiu
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-06       Impact factor: 2.629

10.  Identification of Novel Environmental Substances Relevant to Pediatric Graves' Disease.

Authors:  Qin Xia; Jingjing Liu; Xu Xu; Wei Gu; Kefeng Gu; Xiuli Chen; Rongrong Xie; Dandan Zhang; Haiying Wu; Hui Sun; Fengyun Wang; Linqi Chen; Ting Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.